|
PDGFC expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
8.278000E-03 |
| Normal-vs-Stage3 |
6.26965146466318E-12 |
| Normal-vs-Stage4 |
4.82559999959165E-07 |
| Stage1-vs-Stage2 |
4.078800E-03 |
| Stage1-vs-Stage3 |
3.979600E-01 |
| Stage1-vs-Stage4 |
8.559900E-02 |
| Stage2-vs-Stage3 |
1.077920E-02 |
| Stage2-vs-Stage4 |
1.140970E-01 |
| Stage3-vs-Stage4 |
3.716400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.971100E-04 |
| Normal-vs-Asian |
9.23080000214682E-08 |
| Caucasian-vs-AfricanAmerican |
1.101220E-01 |
| Caucasian-vs-Asian |
3.720000E-01 |
| AfricanAmerican-vs-Asian |
2.531400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.43910480491172E-11 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
3.013000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.44089209850063E-15 |
| Normal-vs-Age(41-60Yrs) |
8.32667268468867E-15 |
| Normal-vs-Age(61-80Yrs) |
2.20570000042386E-07 |
| Normal-vs-Age(81-100Yrs) |
4.759700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.175560E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.578000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.546200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.481800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.932400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.468400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.589400E-01 |
| Classical-VS-Follicular |
2.11279999999814E-05 |
| Classical-VS-Other |
5.348400E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
3.620700E-04 |
| Tall-VS-Other |
3.700200E-01 |
| Tall-VS-Normal |
1.85799997609593E-09 |
| Follicular-VS-Other |
3.806600E-01 |
| Follicular-VS-Normal |
1.324460E-02 |
| Other-VS-Normal |
6.933700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.820799067076E-11 |
| Normal-vs-N1 |
2.19430000003573E-06 |
| N0-vs-N1 |
9.943800E-01 |
|
|
